Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $5.80 Million |
|---|---|
| Enterprise Value | $1.03 Million |
| Earnings per Share | $-0.25 |
| Beta | -0.22 |
| Outstanding Shares | 4,498,772 |
| P/E Ratio | -5.57 |
|---|---|
| PEG | 5.9 |
| Price to Sales | 0.25 |
| Price to Book Ratio | 1.24 |
| Enterprise Value to Revenue | 0.04 |
| Enterprise Value to EBIT | -0.92 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 1.62 |
| Debt to Equity | 0.35 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems that integrate cannabidiol (CBD) with other pharmaceutical compounds. Its operations and development efforts span across the United S...